Adams Clinical

Executive Summary

Adams Clinical operates a network of six clinical research sites across New York, Massachusetts, Pennsylvania, and Texas, specializing in psychiatric, neurological, and ophthalmological trials. Founded in 1993, the company is privately held and serves as a contract research organization (CRO) aiding pharmaceutical companies in bringing new treatments to market. Its sites are strategically located in regions with high patient density and experienced clinical staff, enabling efficient patient recruitment and retention. The company’s model is asset-light and leverages partnerships with sponsors rather than developing its own drugs, providing steady revenue from trial management fees. As demand for CNS and ophthalmology therapies grows, Adams Clinical is positioned to benefit from increased outsourcing of clinical trials by biopharma firms.

Upcoming Catalysts (preview)

• Q4 2026Expansion to New Geographical Markets60% success
• Q2 2027Major Pharma Partnership for Alzheimer’s Trial70% success
• Q3 2026Enrollment Completion of High-Profile Phase 3 Depression Study80% success